Med. praxi. 2016;13(5):268-274

Pharmacotherapy of cough in a nutshell

doc. PharmDr. Jan Juřica, Ph.D.
Farmakologický ústav LF MU v Brně, Biochemický ústav PřF MU v Brně

The article presents in tabular form the types of cough in terms of their symptomatology and the thus recommended pharmacotherapeutic group. Mucoactive agents can be classified into expectorants, mucolytics, mucokinetics, and mucoregulating drugs according to the effect on the composition and amount of sputum produced. Antitussives are divided into centrally and peripherally acting ones. The article presents the crucial pharmacological properties of each substance and/or extracts of medicinal plants. In conclusion, the basic pharmacotherapeutic approaches in treating dry and productive cough are summarized. The combination of antitussives and mucoactive agents are not rational and cannot be recommended.

Keywords: cough, antitussives, mucoregulating drugs, pharmacotherapy

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Juřica J. Pharmacotherapy of cough in a nutshell. Med. praxi. 2016;13(5):268-274.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Čáp P, Vondra V. Akutní a chronický kašel, Mladá fronta 2012: 159.
    2. Rubin B. Mucolytics, expectorants, and mucokinetic medications. Respiratory Care. 2007; 52(7): 859-865.
    3. Dynamed. 2016 Feb 18 ed: EBSCO; 2016.
    4. Lexicomp [online]. [cit. 2016-08-12]. Dostupný z: http://online.lexi.com/action/home.
    5. Thompson GA, Solomon G, Albrecht HH, Reitberg DP, Guenin E. Guaifenesin Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years. J Clin Pharmacol. 2016; 56(7): 894-901. Go to original source... Go to PubMed...
    6. Zanasi A, Lanata L, Fontana G, Saibene F, Dicpinigaitis P, de Blasio F. Multidisciplinary Respiratory Medicine 2015; 10: 19. Go to original source... Go to PubMed...
    7. Juřica J. Farmakologické možnosti v léčbě kašle. Vox pediatriae, Praha: Medix 2014; 14(8): 19-23.
    8. Procházková M, Doležal T. Erdosteinum. Remedia 2004; 14(4): 297-304.
    9. AISLP-2016.3
    10. Balsamo R, Lanata L, Egan CG. Mucoactive drugs. Eur Respir Rev 2010; 19: 116, 127-133. Go to original source... Go to PubMed...
    11. Aliyali M, Poorhasan Amiri A, Sharifpoor A, Zalli F. Effects of N-acetylcysteine on asthma exacerbation. Iran J Allergy Asthma Immunol. 2010; 9(2): 103-109.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.